𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma

✍ Scribed by Anthony D. Ho; Fransisco Del Valle; Heide Rückle; Jürgen Schwammborn; Günter Schlimok; Wolfgang Hiddemann; Peter Meusers; Eckhard Thiel; Bernd Dörken; Werner Hunstein

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
507 KB
Volume
64
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HOAP-Bleo as salvage therapy for diffuse
HOAP-Bleo as salvage therapy for diffuse aggressive non-Hodgkin's lymphoma
✍ R. Liang; D. Todd; T. K. Chan 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 254 KB

A total of 30 patients with recurrent or unresponsive diffuse, aggressive non-Hodgkin's lymphoma, who had previously received doxorubicin, cyclophosphamide, vincristine, and prednisone with or without bleomycin were treated with a combination of doxorubicin, vincristine, ara C, prednisone, and bleom

Ifosfamide and mitoxantrone (I-M) in rel
Ifosfamide and mitoxantrone (I-M) in relapsed and refractory high grade non-Hodgkin's lymphoma and Hodgkin's disease
✍ G. J. Dovey; Dr. J. A. Child; A. V. Simmons; D. L. Barnard; L. Parapia; M. Morga 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 693 KB

Fifty-five patients, initially diagnosed as having advanced high grade non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD) refractory to first-line treatment or in relapse, were treated with ifosfamide 6 g/m', infused over 48 h, followed by mitoxantrone 12 mg/m2. The regimen repeated at three-wee